Works matching IS 10685308 AND DT 2022 AND VI 33 AND IP 12
1
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 9, doi. 10.1002/pu.30957
- Article
2
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 8, doi. 10.1002/pu.30956
- Article
3
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 8, doi. 10.1002/pu.30955
- Article
4
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 8, doi. 10.1002/pu.30954
- Article
5
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 7, doi. 10.1002/pu.30953
- Article
6
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 7, doi. 10.1002/pu.30952
- Article
7
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 6, doi. 10.1002/pu.30951
- Article
8
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 4, doi. 10.1002/pu.30950
- Article
9
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 3, doi. 10.1002/pu.30949
- Article
10
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 2, doi. 10.1002/pu.30948
- Article
11
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 1, doi. 10.1002/pu.30947
- Article
12
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 1, doi. 10.1002/pu.30946
- Article